echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Johnson & Johnson Medical and Beijing Bethune Charity Foundation launch 2021 China Atrial Fibrillation Day...

    Johnson & Johnson Medical and Beijing Bethune Charity Foundation launch 2021 China Atrial Fibrillation Day...

    • Last Update: 2021-06-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Coinciding with the ninth "Chinese Atrial Fibrillation Day", Johnson & Johnson joined hands with Beijing Bethune Charity Foundation to launch the "Medical Road Accompaniment"-2021 China Atrial Fibrillation Day Disease Popularization Public Welfare Communication Project, and launched the "Caring Heart, Love Brain, Healthy Life"—— 2021 China Atrial Fibrillation Day specially planned themed event.


    Sun Zhiwei, chairman of the Beijing Bethune Charity Foundation, said in the opening speech of this event: “As a charitable organization focusing on the medical and health field, Beijing Bethune Charity Foundation has always paid attention to heart and brain health, especially the prevention and treatment of atrial fibrillation.


    Heart and brain health challenges cannot be ignored, early diagnosis and treatment are the key

    Heart and brain health challenges cannot be ignored, early diagnosis and treatment are the key

    In May of this year, the National Bureau of Statistics released the main data of the seventh national census.


    Atrial fibrillation is a supraventricular tachyarrhythmia characterized by rapid and disordered atrial electrical activity.


    Because some symptoms of atrial fibrillation are not obvious, but the risk of stroke and heart failure is not much or even greater.


    In recent years, the advancement of medical technology has provided more and more scientific diagnosis and treatment concepts and methods for atrial fibrillation, making it possible to cure atrial fibrillation.


    Exploring the path of healthy China's "heart" and comprehensively boosting heart and brain health

    Exploring the path of healthy China's "heart" and comprehensively boosting heart and brain health

    At the moment, "Healthy China" has been elevated to a national strategy.


    Yao Yan, deputy director of the Arrhythmia Center of Fuwai Hospital of the Chinese Academy of Medical Sciences and director of the Arrhythmia No.


    At present, cardiovascular and cerebrovascular treatment are divided into two different departments.


    Among patients with atrial fibrillation, the majority of primary-level patient groups are trapped by disease awareness and local medical resources and service levels, and the treatment situation they face is particularly difficult.


    Chen Xi, General Manager of the Cardiovascular and Professional Solutions Division of Johnson & Johnson Medical in China, said: "In addition to continuously bringing innovative treatment methods to patients, Johnson & Johnson Medical has joined hands with various parties to improve the accessibility of atrial fibrillation treatment, such as the county atrial fibrillation center.


    In addition, building a multi-level medical security system to help patients reduce the economic burden of disease treatment and further improve the accessibility of treatment is another important way to fully realize heart and brain health.


    In this specially planned theme event, young surgeons from the front line of cardiovascular therapy across the country represented Wang Changhui, chief physician of the Department of Cardiovascular Medicine, the First Affiliated Hospital of Anhui Medical University, Wang Changhui, deputy director of the Department, and Director of the First Arrhythmia Department of the First Affiliated Hospital of Dalian Medical University Yin Xiaomeng and Jiang Weifeng, the attending physician of the Department of Cardiology, Shanghai Jiao Tong University Chest Hospital, used ingenious theater-style lectures to vividly share the "heart" story of the doctor-patient relationship in clinical treatment through the intuitive perspective of clinicians, and continue to deliver the correct prevention and treatment of atrial fibrillation.


    "Healthy Chinese Heart" requires the joint efforts of the government, medical institutions, doctors, enterprises, and non-profit organizations.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.